{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T21:34:22Z","timestamp":1648589662122},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1998,1,1]],"date-time":"1998-01-01T00:00:00Z","timestamp":883612800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[1998,1]]},"DOI":"10.1007\/bf03347285","type":"journal-article","created":{"date-parts":[[2014,3,29]],"date-time":"2014-03-29T06:20:42Z","timestamp":1396074042000},"page":"43-47","source":"Crossref","is-referenced-by-count":5,"title":["Parathyroid hormone suppression by 22-oxacalcitriol in the severe parathyroid hyperplasia"],"prefix":"10.1007","volume":"21","author":[{"given":"H.","family":"Funahashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Imai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Tsukamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Kikumori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Oiwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Tominaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,29]]},"reference":[{"key":"BF03347285_CR1","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1172\/JCI111639","volume":"74","author":"E Slatopolsky","year":"1984","unstructured":"Slatopolsky E., Weerts C., Thielan J., Horst R., Harter H., Martin K.J. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients. J. Clin. Invest. 74: 2136, 1984.","journal-title":"J. Clin. Invest."},{"key":"BF03347285_CR2","first-page":"S43","volume":"42","author":"E Slatopolsky","year":"1992","unstructured":"Slatopolsky E., Berkoben M., Kelber J., Brown A., Delmez J. Effects of calcitriol and non-calcemic vitamin D analogs on secondary hyperparathyroidism. Kidney Int. 42: S43, 1992.","journal-title":"Kidney Int."},{"key":"BF03347285_CR3","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/jbmr.5650070713","volume":"7","author":"JL Finch","year":"1992","unstructured":"Finch J.L., Brown A.J., Mori T., Nishii Y., Slatopolsky E. Suppression of PTH and decreased action on bone are partially responsible for the low calcemic activity of 22-oxacalcitriol relative to 1,25-(OH)2D3. J. Bone Miner. Res. 7: 835, 1992.","journal-title":"J. Bone Miner. Res."},{"key":"BF03347285_CR4","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1172\/JCI114229","volume":"84","author":"AJ Brown","year":"1989","unstructured":"Brown A.J., Ritter C.R., Finch J.L., Morrissey J., Martin K.J., Murayama E., Nishii Y., Slatopolsky E. The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion. J. Clin. Invest. 84: 728, 1989.","journal-title":"J. Clin. Invest."},{"key":"BF03347285_CR5","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1210\/endo.133.6.8243296","volume":"133","author":"T Naveh-Many","year":"1993","unstructured":"Naveh-Many T., Silver J. Effects of calcitriol, 22-oxacalcitriol, and calcipotriol on serum calcium and parathyroid hormone gene expression. Endocrinology 133: 2724, 1993.","journal-title":"Endocrinology"},{"key":"BF03347285_CR6","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/00041552-199607000-00008","volume":"5","author":"Y Tominaga","year":"1996","unstructured":"Tominaga Y., Takagi H. Molecular genetics of hyperparathyroid disease. Curr. Opin. Nephrol. Hypertens. 5: 336, 1996.","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"BF03347285_CR7","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/s002689900105","volume":"20","author":"Y Tanaka","year":"1996","unstructured":"Tanaka Y., Funahashi H., Imai T., Wada M., Tominaga Y., Mishra S.K., Takagi H. Functional and morphometric study of cryopreserved human parathyroid transplanted into nude mice. World J. Surg. 20: 692, 1996.","journal-title":"World J. Surg."},{"key":"BF03347285_CR8","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/ki.1993.377","volume":"44","author":"H Reichel","year":"1993","unstructured":"Reichel H., Szabo A., Uhl J., Pessan S., Schmatz A., Schmidt-Gayk H., Ritz E. Intermittent versus continuous administration of 1,25-dihydroxyvitamin D3 in experimental renal hyperparathyroidism. Kidney Int. 44: 1259, 1993.","journal-title":"Kidney Int."},{"key":"BF03347285_CR9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1507\/endocrj.42.9","volume":"42","author":"Y Tanaka","year":"1995","unstructured":"Tanaka Y., Funahashi H., Imai T., Tobinaga J., Murase H., Andoh H., Wada M., Matsuyama T., Tominaga Y., Takagi H. Heterotransplantation of human parathyroid glands into nude mice. Endocrine J. 42: 9, 1995.","journal-title":"Endocrine J."},{"key":"BF03347285_CR10","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1159\/000189144","volume":"73","author":"Y Tanaka","year":"1996","unstructured":"Tanaka Y., Funahashi H., Imai T., Seo H., Tominaga Y., Takagi H. Oxyphil cell function in secondary parathyroid hyperplasia. Nephron 73: 580, 1996.","journal-title":"Nephron"},{"key":"BF03347285_CR11","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0006-291X(92)92266-Z","volume":"189","author":"AJ Brown","year":"1992","unstructured":"Brown A.J., Berkoben M., Ritter C., Kubodera N., Nishii Y., Slatopolsky E. Metabolism of 22-oxacalcitriol by a vitamin D-inducible pathway in cultured parathyroid cells. Biochem. Biophys. Res. Commun. 189: 759, 1992.","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BF03347285_CR12","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/8756-3282(95)00215-Y","volume":"17","author":"MM Friedlaender","year":"1995","unstructured":"Friedlaender M.M., Yagil Y., Wald H., Popovtzer M.M. 22-oxacalcitriol does not interfere with parathyroid hormone-induced phosphaturia or cyclic-AMP excretion. Bone 17: 301, 1995.","journal-title":"Bone"},{"key":"BF03347285_CR13","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/0006-2952(94)90508-8","volume":"48","author":"N Akeno","year":"1994","unstructured":"Akeno N., Saikatsu S., Kimura S., Horiuchi N. Induction of vitamin D 24-hydroxylase messenger RNA and activity by 22-oxacalcitriol in mouse kidney and duodenum. Possible role in decrease of plasma 1 alpha, 25-dihydroxyvitamin D3. Biochem. Pharmacol. 48: 2081, 1994.","journal-title":"Biochem. Pharmacol."},{"key":"BF03347285_CR14","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1210\/endo.130.6.1597134","volume":"130","author":"AS Dusso","year":"1992","unstructured":"Dusso A.S., Negrea L., Finch J., Kamimura S., Lopez-Hilker S., Mori T., Nishii Y., Brown A., Slapopolski E The effect of 22-oxacalcitriol on serum calcitriol. Endocrinology 130: 3129, 1992.","journal-title":"Endocrinology"},{"key":"BF03347285_CR15","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/BF00582166","volume":"50","author":"M Takizawa","year":"1992","unstructured":"Takizawa M., Fallon M., Stein B., Epstein S. The effect of a new vitamin D analog, 22-oxa-1\u03b1,25(OH)2D3, on bone mineral metabolism in normal male rats. Calcif. Tissue Int. 50: 521, 1992.","journal-title":"Calcif. Tissue Int."},{"key":"BF03347285_CR16","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1530\/eje.0.1330618","volume":"133","author":"M Kanatani","year":"1995","unstructured":"Kanatani M., Sugimoto T., Kaji H., Kano J., Chihara K. Effects of 22-oxacalcitriol on bone metabolism in vitro: comparison with calcitriol \u2014 effects of 22-oxacalcitriol on osteoclast-like cell formation and bone-resorbing activity. Eur. J. Endocrinol. 133: 618, 1995.","journal-title":"Eur. J. Endocrinol."},{"key":"BF03347285_CR17","doi-asserted-by":"crossref","first-page":"8184","DOI":"10.1021\/bi00083a019","volume":"32","author":"PW Jurutka","year":"1993","unstructured":"Jurutka P.W., Terpening C.M., Haussler M.R. The 1,25-dihydroxy-vitamin D3 receptor is phosphorylated in response to 1,25-dihydroxy-vitamin D3 and 22-oxacalcitriol in rat osteoblasts, and by casein kinase II, in vitro. Biochemistry 32: 8184, 1993.","journal-title":"Biochemistry"},{"key":"BF03347285_CR18","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/ki.1993.83","volume":"43","author":"JL Finch","year":"1993","unstructured":"Finch J.L., Brown A.J., Kubodera N., Nishii Y., Slatopolsky E. Differential effects of 1,25-(OH)2D3 and 22-oxacalcitriol on phosphate and calcium metabolism. Kidney Int. 43: 561, 1993.","journal-title":"Kidney Int."},{"key":"BF03347285_CR19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF02555797","volume":"48","author":"MM Ladizesky","year":"1991","unstructured":"Ladizesky M.M., Diaz M., Zeni S., Romeo H.E., Cardinali D.P., Mantalen C.A. Compensatory parathyroid hypertrophy after hemiparathyroidectomy in rats feeding a low calcium diet. Calcif. Tissue Int. 48: 63, 1991.","journal-title":"Calcif. Tissue Int."},{"key":"BF03347285_CR20","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1172\/JCI112666","volume":"78","author":"S Lopez-Hilker","year":"1986","unstructured":"Lopez-Hilker S., Galceran T., Chan Y., Rapp N., Martin K.J., Slatopolsky E. Hypocalcemia may not be essential for the development of secondary hyperparathyroidism in chronic renal failure. J. Clin. Invest. 78: 1097, 1986.","journal-title":"J. Clin. Invest."},{"key":"BF03347285_CR21","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1172\/JCI118224","volume":"96","author":"T Naveh-Many","year":"1995","unstructured":"Naveh-Many T., Rahamimov R., Livni N. Parathyroid cell proliferation in normal and chronic renal failure rats. The effect of calcium, phosphate, and vitamin D. J. Clin. Invest 96: 1786, 1995.","journal-title":"J. Clin. Invest"},{"key":"BF03347285_CR22","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1210\/endo.132.6.8389284","volume":"132","author":"J Russell","year":"1993","unstructured":"Russell J., Bar A., Sherwood L.M., Hurwitz S. Interaction between calcium and 1,25-dihydroxyvitamin D3 in the regulation of preproparathyroid hormone and vitamin D receptor messenger ribonucleic acid in avian parathyroids. Endocrinology 132: 2639, 1993.","journal-title":"Endocrinology"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03347285.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03347285\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03347285","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T21:58:30Z","timestamp":1565301510000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03347285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,1]]}},"alternative-id":["BF03347285"],"URL":"https:\/\/doi.org\/10.1007\/bf03347285","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,1]]}}}